The article discusses the potential of fecal microbiota transplantation (FMT) in restoring gut barrier function and immunity in patients with cirrhosis. Cirrhosis is a condition characterized by liver damage and is associated with intestinal barrier dysfunction, leading to increased bacterial translocation and immune system activation. FMT involves the transfer of healthy fecal microbiota from a donor to a recipient, with the aim of restoring a balanced gut microbiome.
Keep Reading
Add A Comment